Chui MH - Search Results

1

In-depth molecular profiling of the biphasic components of uterine carcinosarcomas.

McConechy MK, Hoang LN, Chui MH, Senz J, Yang W, Rozenberg N, Mackenzie R, McAlpine JN, Huntsman DG, Clarke BA, Gilks CB, Lee CH. McConechy MK, et al. Among authors: chui mh. J Pathol Clin Res. 2015 Apr 9;1(3):173-85. doi: 10.1002/cjp2.18. eCollection 2015 Jul. J Pathol Clin Res. 2015. PMID: 27499902 Free PMC article.

2

Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype.

Chui MH, Gilks CB, Cooper K, Clarke BA. Chui MH, et al. Adv Anat Pathol. 2013 Nov;20(6):378-86. doi: 10.1097/PAP.0b013e3182a92cf8. Adv Anat Pathol. 2013. PMID: 24113308 Review.

3

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

Wu RC, Ayhan A, Maeda D, Kim KR, Clarke BA, Shaw P, Chui MH, Rosen B, Shih IeM, Wang TL. Wu RC, et al. Among authors: chui mh. J Pathol. 2014 Mar;232(4):473-81. doi: 10.1002/path.4315. J Pathol. 2014. PMID: 24338723 Free PMC article.

4

Displaced granulosa cells within the ovarian stroma in a BRCA1 mutation carrier.

Chui MH, Chapman WB, Clarke BA. Chui MH, et al. Int J Gynecol Pathol. 2014 Jul;33(4):423-4. doi: 10.1097/PGP.0b013e3182a3cd2c. Int J Gynecol Pathol. 2014. PMID: 24901403 No abstract available.

5

The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.

Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA. Chui MH, et al. Am J Surg Pathol. 2014 Sep;38(9):1173-81. doi: 10.1097/PAS.0000000000000298. Am J Surg Pathol. 2014. PMID: 25025451

6

Genomic profiling identifies GPC5 amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas.

Chui MH, Have C, Hoang LN, Shaw P, Lee CH, Clarke BA. Chui MH, et al. J Pathol Clin Res. 2018 Jan 24;4(1):69-78. doi: 10.1002/cjp2.89. eCollection 2018 Jan. J Pathol Clin Res. 2018. PMID: 29416878 Free PMC article.

7

Oncogenic BRAF and KRAS mutations in endosalpingiosis.

Chui MH, Shih IM. Chui MH, et al. J Pathol. 2020 Feb;250(2):148-158. doi: 10.1002/path.5353. Epub 2019 Nov 29. J Pathol. 2020. PMID: 31576556 Free PMC article.

8

Somatic intronic TP53 c.375+5G mutations are a recurrent but under-recognized mode of TP53 inactivation.

Chui MH, Yang C, Mehta N, Rai V, Zehir A, Momeni Boroujeni A, Ladanyi M, Mandelker D. Chui MH, et al. J Pathol Clin Res. 2022 Jan;8(1):14-18. doi: 10.1002/cjp2.242. Epub 2021 Sep 10. J Pathol Clin Res. 2022. PMID: 34505757 Free PMC article.

9

Decreased HER2 expression in endometrial cancer following anti-HER2 therapy.

Chui MH, Brown DN, Da Cruz Paula A, da Silva EM, Momeni-Boroujeni A, Reis-Filho JS, Zhang Y, Makker V, Ellenson LH, Weigelt B. Chui MH, et al. J Pathol. 2024 Feb;262(2):129-136. doi: 10.1002/path.6230. Epub 2023 Nov 27. J Pathol. 2024. PMID: 38013631

10

Primary Marginal Zone Lymphoma of the Subcutis Associated With Panniculitis and Fat Necrosis.

Chui MH, Kukreti V, Wei C, Delabie J. Chui MH, et al. Am J Clin Pathol. 2015 Aug;144(2):341-6. doi: 10.1309/AJCPQH8K5TNUADLV. Am J Clin Pathol. 2015. PMID: 26185321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters